Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK

OBJECTIVE: To examine the clinical and economic impact of vedolizumab compared with conventional therapy in the treatment of moderately-to-severely active ulcerative colitis (UC) in the UK based on results of the GEMINI I trial. METHODS: A decision-analytic model in Microsoft Excel was used to compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Michele R, Azzabi Zouraq, Ismail, Chevrou-Severac, Helene, Selby, Ross, Kerrigan, Matthew C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652924/
https://www.ncbi.nlm.nih.gov/pubmed/29081667
http://dx.doi.org/10.2147/CEOR.S135609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652924/
https://www.ncbi.nlm.nih.gov/pubmed/29081667
http://dx.doi.org/10.2147/CEOR.S135609

Ejemplares similares